Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new combination pill has been given the green light by the National Institute for Health and Care Excellence (Nice) to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A transformational new pill for treating endometriosis has been approved for use on the NHS across England. The new tablet, ...

A new pill designed to transform the treatment of endometriosis has been approved for use on the NHS. The combination drug ...

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. A first-of-its-kind pill for endometriosis has been approved for NHS use, offering hope for people ...

The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

The new pill is the first long-term daily pill licensed to treat the condition, and works by blocking specific hormones that ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

But now the NHS England has approved a daily pill that could help manage pain and other symptoms for those living with the ...